Current and historical daily PE Ratio for Senzime AB (
OSTO:SEZI
) from 2008 to Sep 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Senzime AB stock (OSTO:SEZI) PE ratio as of Sep 25 2024 is 0.
More Details
Senzime AB (OSTO:SEZI) PE Ratio (TTM) Chart
Senzime AB (OSTO:SEZI) PE Ratio (TTM) Historical Data
View and export this data going back to 2008. Start your Free Trial
Total 1288
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Senzime AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-26 | At Loss | 2024-07-25 | At Loss |
| 2024-09-25 | At Loss | 2024-07-24 | At Loss |
| 2024-09-24 | At Loss | 2024-07-23 | At Loss |
| 2024-09-23 | At Loss | 2024-07-22 | At Loss |
| 2024-09-20 | At Loss | 2024-07-19 | At Loss |
| 2024-09-19 | At Loss | 2024-07-18 | At Loss |
| 2024-09-18 | At Loss | 2024-07-17 | At Loss |
| 2024-09-17 | At Loss | 2024-07-16 | At Loss |
| 2024-09-16 | At Loss | 2024-07-15 | At Loss |
| 2024-09-13 | At Loss | 2024-07-12 | At Loss |
| 2024-09-12 | At Loss | 2024-07-11 | At Loss |
| 2024-09-11 | At Loss | 2024-07-10 | At Loss |
| 2024-09-10 | At Loss | 2024-07-09 | At Loss |
| 2024-09-09 | At Loss | 2024-07-08 | At Loss |
| 2024-09-06 | At Loss | 2024-07-05 | At Loss |
| 2024-09-05 | At Loss | 2024-07-04 | At Loss |
| 2024-09-04 | At Loss | 2024-07-03 | At Loss |
| 2024-09-03 | At Loss | 2024-07-02 | At Loss |
| 2024-09-02 | At Loss | 2024-07-01 | At Loss |
| 2024-08-30 | At Loss | 2024-06-28 | At Loss |
| 2024-08-29 | At Loss | 2024-06-27 | At Loss |
| 2024-08-28 | At Loss | 2024-06-26 | At Loss |
| 2024-08-27 | At Loss | 2024-06-25 | At Loss |
| 2024-08-26 | At Loss | 2024-06-24 | At Loss |
| 2024-08-23 | At Loss | 2024-06-20 | At Loss |
| 2024-08-22 | At Loss | 2024-06-19 | At Loss |
| 2024-08-21 | At Loss | 2024-06-18 | At Loss |
| 2024-08-20 | At Loss | 2024-06-17 | At Loss |
| 2024-08-19 | At Loss | 2024-06-14 | At Loss |
| 2024-08-16 | At Loss | 2024-06-13 | At Loss |
| 2024-08-15 | At Loss | 2024-06-12 | At Loss |
| 2024-08-14 | At Loss | 2024-06-11 | At Loss |
| 2024-08-13 | At Loss | 2024-06-10 | At Loss |
| 2024-08-12 | At Loss | 2024-06-07 | At Loss |
| 2024-08-09 | At Loss | 2024-06-05 | At Loss |
| 2024-08-08 | At Loss | 2024-06-04 | At Loss |
| 2024-08-07 | At Loss | 2024-06-03 | At Loss |
| 2024-08-06 | At Loss | 2024-05-31 | At Loss |
| 2024-08-05 | At Loss | 2024-05-30 | At Loss |
| 2024-08-02 | At Loss | 2024-05-29 | At Loss |
| 2024-08-01 | At Loss | 2024-05-28 | At Loss |
| 2024-07-31 | At Loss | 2024-05-27 | At Loss |
| 2024-07-30 | At Loss | 2024-05-24 | At Loss |
| 2024-07-29 | At Loss | 2024-05-23 | At Loss |
| 2024-07-26 | At Loss | 2024-05-22 | At Loss |
Senzime AB (OSTO:SEZI) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Senzime AB
NAICS : 339112
SIC : 3841
ISIN : SE0002478776
Compare
Compare
Traded in other countries / regions
SEZI.SwedenSNZZF.USA6YC.Germany IPO Date
2008-06-18Description
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers